Teva Pharmaceutical Industries
TEVA
$7.23
Share price
0.42%
Change (1 day)
-22.26%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - Net assets
Net assets on the balance sheet as of December 2022 : $8.69 B
According to Teva Pharmaceutical Industries's latest financial reports the company has $8.69 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Teva Pharmaceutical Industries - Net assets on balance sheet (from 2001 to 2022)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $8.69 B | -22.71% |
| 2021-12-31 | $11.24 B | 1.65% |
| 2020-12-31 | $11.06 B | -26.57% |
| 2019-12-31 | $15.06 B | -4.63% |
| 2018-12-31 | $15.79 B | -15.74% |
| 2017-12-31 | $18.74 B | -46.43% |
| 2016-12-31 | $34.99 B | 16.93% |
| 2015-12-31 | $29.92 B | 28.14% |
| 2014-12-31 | $23.35 B | 3.18% |
| 2013-12-31 | $22.63 B | -1.01% |
| 2012-12-31 | $22.86 B | 2.35% |
| 2011-12-31 | $22.34 B | 1.55% |
| 2010-12-31 | $22.00 B | 14.24% |
| 2009-12-31 | $19.25 B | 17.72% |
| 2008-12-31 | $16.36 B | 18.9% |
| 2007-12-31 | $13.76 B | 23.11% |
| 2006-12-31 | $11.17 B | 84.73% |
| 2005-12-31 | $6.05 B | 12.05% |
| 2004-12-31 | $5.39 B | 63.82% |
| 2003-12-31 | $3.29 B | 79.69% |
| 2002-12-31 | $1.83 B | 32.65% |
| 2001-12-31 | $1.38 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $52.14 B | 499.95% | 🇨🇭 Switzerland |
 Pfizer PFE | $95.91 B | 1,003.62% | 🇺🇸 USA |
 Sanofi SNY | $80.48 B | 826.08% | 🇫🇷 France |
 Merck MRK | $46.05 B | 429.95% | 🇺🇸 USA |
 AstraZeneca AZN | $35.81 B | 312.05% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $14.01 B | 61.23% | 🇬🇧 UK |
 Dr. Reddy's RDY | $2.53 B | -70.88% | 🇮🇳 India |